Brad Bolzon

About Brad Bolzon

Brad Bolzon combines 13 years of senior R&D and business development experience at Eli Lilly and Roche with his role as architect of Versant's cross-border company-creation strategy, including co-founding Inception Sciences as a shared discovery platform that spins out multiple biotech startups. He has served as founding chairman or long-term board leader at flagship companies like CRISPR Therapeutics for over a decade, while building Versant's multi-hub presence across the US, Canada, and Europe.

Focus Areas

Investment Stage

Notable Investments